BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

511 related articles for article (PubMed ID: 17959774)

  • 41. CCDC141 Mutations in Idiopathic Hypogonadotropic Hypogonadism.
    Turan I; Hutchins BI; Hacihamdioglu B; Kotan LD; Gurbuz F; Ulubay A; Mengen E; Yuksel B; Wray S; Topaloglu AK
    J Clin Endocrinol Metab; 2017 Jun; 102(6):1816-1825. PubMed ID: 28324054
    [TBL] [Abstract][Full Text] [Related]  

  • 42. PROKR2 missense mutations associated with Kallmann syndrome impair receptor signalling activity.
    Monnier C; Dodé C; Fabre L; Teixeira L; Labesse G; Pin JP; Hardelin JP; Rondard P
    Hum Mol Genet; 2009 Jan; 18(1):75-81. PubMed ID: 18826963
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Idiopathic hypogonadotropic hypogonadism caused by compound heterozygosity for two novel mutations in the GNRH1 gene: a case report.
    Tian Q; Tang J; Wang L; Liu J; Li X; Cao Z; Tian Z
    BMC Endocr Disord; 2023 Oct; 23(1):213. PubMed ID: 37798680
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Children with idiopathic hypogonadotropic hypogonadism: clinical data analysis and mutations analysis of KAL1 and FGFR1 gene].
    Qin M; Gong C; Qi Z; Wu D; Liu M; Gu Y; Cao B; Li W; Liang X
    Zhonghua Er Ke Za Zhi; 2014 Dec; 52(12):942-7. PubMed ID: 25619354
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Induction of puberty with human chorionic gonadotropin (hCG) followed by reversal of hypogonadotropic hypogonadism in Kallmann syndrome.
    Pierzchlewska MM; Robaczyk MG; Vogel I
    Endokrynol Pol; 2017; 68(6):692-696. PubMed ID: 29022642
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Posttranslational Modification Defects in Fibroblast Growth Factor Receptor 1 as a Reason for Normosmic Isolated Hypogonadotropic Hypogonadism.
    Ying H; Sun Y; Wu H; Jia W; Guan Q; He Z; Gao L; Zhao J; Ji Y; Li G; Xu C
    Oxid Med Cell Longev; 2020; 2020():2358719. PubMed ID: 33299522
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The prevalence of digenic mutations in patients with normosmic hypogonadotropic hypogonadism and Kallmann syndrome.
    Quaynor SD; Kim HG; Cappello EM; Williams T; Chorich LP; Bick DP; Sherins RJ; Layman LC
    Fertil Steril; 2011 Dec; 96(6):1424-1430.e6. PubMed ID: 22035731
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Genetic insights into human isolated gonadotropin deficiency.
    Trarbach EB; Silveira LG; Latronico AC
    Pituitary; 2007; 10(4):381-91. PubMed ID: 17624596
    [TBL] [Abstract][Full Text] [Related]  

  • 49. PROK2/PROKR2 Signaling and Kallmann Syndrome.
    Dodé C; Rondard P
    Front Endocrinol (Lausanne); 2013; 4():19. PubMed ID: 23596439
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pleiotropic effects of prokineticin 2 in the control of energy metabolism.
    Magnan C; Migrenne-Li S
    Biochimie; 2021 Jul; 186():73-81. PubMed ID: 33932486
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Defective AMH signaling disrupts GnRH neuron development and function and contributes to hypogonadotropic hypogonadism.
    Malone SA; Papadakis GE; Messina A; Mimouni NEH; Trova S; Imbernon M; Allet C; Cimino I; Acierno J; Cassatella D; Xu C; Quinton R; Szinnai G; Pigny P; Alonso-Cotchico L; Masgrau L; Maréchal JD; Prevot V; Pitteloud N; Giacobini P
    Elife; 2019 Jul; 8():. PubMed ID: 31291191
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Clinical and genetic features of 64 young male paediatric patients with congenital hypogonadotropic hypogonadism.
    Wang Y; Gong C; Qin M; Liu Y; Tian Y
    Clin Endocrinol (Oxf); 2017 Dec; 87(6):757-766. PubMed ID: 28833369
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clinical, endocrinological, and molecular characterization of Kallmann syndrome and normosmic idiopathic hypogonadotropic hypogonadism: a single center experience.
    Shin SJ; Sul Y; Kim JH; Cho JH; Kim GH; Kim JH; Choi JH; Yoo HW
    Ann Pediatr Endocrinol Metab; 2015 Mar; 20(1):27-33. PubMed ID: 25883924
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A comparative phenotypic study of kallmann syndrome patients carrying monoallelic and biallelic mutations in the prokineticin 2 or prokineticin receptor 2 genes.
    Sarfati J; Guiochon-Mantel A; Rondard P; Arnulf I; Garcia-Piñero A; Wolczynski S; Brailly-Tabard S; Bidet M; Ramos-Arroyo M; Mathieu M; Lienhardt-Roussie A; Morgan G; Turki Z; Bremont C; Lespinasse J; Du Boullay H; Chabbert-Buffet N; Jacquemont S; Reach G; De Talence N; Tonella P; Conrad B; Despert F; Delobel B; Brue T; Bouvattier C; Cabrol S; Pugeat M; Murat A; Bouchard P; Hardelin JP; Dodé C; Young J
    J Clin Endocrinol Metab; 2010 Feb; 95(2):659-69. PubMed ID: 20022991
    [TBL] [Abstract][Full Text] [Related]  

  • 55. GnRH, anosmia and hypogonadotropic hypogonadism--where are we?
    Forni PE; Wray S
    Front Neuroendocrinol; 2015 Jan; 36():165-77. PubMed ID: 25306902
    [TBL] [Abstract][Full Text] [Related]  

  • 56. CCDC141 Mutation Identified in Anosmic Hypogonadotropic Hypogonadism (Kallmann Syndrome) Alters GnRH Neuronal Migration.
    Hutchins BI; Kotan LD; Taylor-Burds C; Ozkan Y; Cheng PJ; Gurbuz F; Tiong JD; Mengen E; Yuksel B; Topaloglu AK; Wray S
    Endocrinology; 2016 May; 157(5):1956-66. PubMed ID: 27014940
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Nasal embryonic LHRH factor (NELF) mutations in patients with normosmic hypogonadotropic hypogonadism and Kallmann syndrome.
    Xu N; Kim HG; Bhagavath B; Cho SG; Lee JH; Ha K; Meliciani I; Wenzel W; Podolsky RH; Chorich LP; Stackhouse KA; Grove AM; Odom LN; Ozata M; Bick DP; Sherins RJ; Kim SH; Cameron RS; Layman LC
    Fertil Steril; 2011 Apr; 95(5):1613-20.e1-7. PubMed ID: 21300340
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Phenotypic and genotypic landscape of PROKR2 in neuroendocrine disorders.
    Martinez-Mayer J; Perez-Millan MI
    Front Endocrinol (Lausanne); 2023; 14():1132787. PubMed ID: 36843573
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Multiplex ligation dependent probe amplification analysis of KAL1, GNRH1, GNRHR, PROK2 and PROKR2 in male patients with idiopathic hypogonadotropic hypogonadism.
    Basaran Y; Bolu E; Unal HU; Sagkan RI; Taslipinar A; Ozgurtas T; Musabak U
    Endokrynol Pol; 2013; 64(4):285-92. PubMed ID: 24002956
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Expanding the genetic spectrum of ANOS1 mutations in patients with congenital hypogonadotropic hypogonadism.
    Gonçalves CI; Fonseca F; Borges T; Cunha F; Lemos MC
    Hum Reprod; 2017 Mar; 32(3):704-711. PubMed ID: 28122887
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.